🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "focused action to address household expense pressures" in the forthcoming financial statement.

Speaking to media outlets, she emphasized that curbing inflation is a shared task of both the administration and the central bank.

The United Kingdom's price growth is forecast to be the most elevated among the G7 advanced economies this year and the following year.

Potential Energy Cost Measures

It is understood the administration could take action to bring down utility costs, such as by cutting the present 5% rate of VAT applied on energy supplies.

A further possibility is to cut some of the government charges currently added to household expenses.

Budgetary Constraints and Analyst Expectations

The administration will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for these measures.

The consensus from most analysts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to fulfill her declared borrowing rules.

Earlier on Thursday, calculations indicated there was a £22bn gap for the Treasury chief to address, which is at the lower end of expectations.

"There's a shared job between the central bank and the administration to continue tackling some of the sources of inflation," Reeves stated to the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Commitments and International Issues

While a great deal of the attention has been on probable tax increases, the Treasury chief said the most recent information from the OBR had not altered her vow to election pledges not to increase rates on income tax, VAT or National Insurance.

She blamed an "uncertain world" with increasing international and trade concerns for the fiscal tax moves, likely to be directed on those "with the broadest shoulders."

Global Trade Disputes

Addressing concerns about the UK's commercial links with the Asian nation she said: "The UK's security interests invariably come first."

Last week's statement by Chinese authorities to increase export controls on critical minerals and other materials that are essential for advanced tech manufacturing led American leader Donald Trump to suggest an extra 100% import tax on imports from China, raising the prospect of an all-out trade war between the two economic giants.

The American finance chief described the Chinese decision "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the American proposal to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the move was "bad for the world economy and causes additional challenges."

"In my view there are sectors where we need to challenge Chinese policies, but there are also valuable chances to sell into China's economy, including banking sector and other sectors of the economic system. We've got to maintain that equilibrium appropriate."

The Treasury chief also stated she was collaborating with international partners "on our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Costs and Investment

Reeves also recognized that the price the NHS pays for drugs could increase as a consequence of current talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and investment.

Some of the biggest global drug companies have said in recent statements that they are either pausing or canceling projects in the UK, with some attributing the modest returns they are receiving.

Recently, the Science Minister said the cost the health service spends on drugs would must rise to stop businesses and drug research funding leaving the UK.

Reeves informed media: "It has been observed because of the cost structure, that clinical trials, new drugs have not been available in the United Kingdom in the way that they are in other continental states."

"Our aim is to ensure that individuals getting care from the NHS are able to obtain the best life-saving medicines in the globe. And so we are examining these issues, and... aiming to obtain increased capital into the UK."